ライフサイエンスコーパス: caffeinated

1 ed coffee in the NHS (P < 0.0001) and 4% for caffeinated and 7% for decaffeinated coffee in the HPFS

2 Consumption of caffeinated and artificially sweetened soft drinks was p

3 nd dietary risk factors were controlled for, caffeinated and caffeine-free SSB intake was significant

4 High intake of caffeinated and decaffeinated coffee (2 or more cups/day

5 als Follow-up Study, we associated intake of caffeinated and decaffeinated coffee after diagnosis of

6 The association between consumption of caffeinated and decaffeinated coffee and risk of mortali

7 ver the past 4 y concluded that ingestion of caffeinated and decaffeinated coffee can reduce the risk

8 ve study aimed to examine the consumption of caffeinated and decaffeinated coffee in relation to card

9 wer risk of T2D [RR per serving: 8% for both caffeinated and decaffeinated coffee in the NHS (P < 0.0

10 This study examined the association of caffeinated and decaffeinated coffee intake with cogniti

11 Conversely, the consumption of caffeinated and decaffeinated coffee was associated with

12 Trends were similar between caffeinated and decaffeinated coffee.

13 was to assess the relation between long-term caffeinated and decaffeinated filtered coffee consumptio

14 We evaluated coffee and tea intakes (caffeinated and decaffeinated) in relation to colon (pro

15 spective associations between consumption of caffeinated and noncaffeinated sugar- and artificially s

16 Consumption of total, caffeinated, and decaffeinated coffee were nonlinearly a

17 ed the associations of consumption of total, caffeinated, and decaffeinated coffee with risk of subse

18 and mortality in aging, we hypothesized that caffeinated beverage consumption decreases the risk of c

19 xamined the association between caffeine and caffeinated beverage consumption in relation to the risk

20 e assessed the relation between caffeine and caffeinated beverage intake and reproductive hormones in

21 ephone interview collected information about caffeinated beverage intake as well as other lifestyle,

22 Participants aged >or=65 y with higher caffeinated beverage intake exhibited lower relative ris

23 Findings support recommendations to limit caffeinated beverage intake for LUTS, and in men, they s

24 evant mechanism for the protective effect of caffeinated beverage intake in human epidemiologic studi

25 e mortality than did participants with lower caffeinated beverage intake.

26 (24HDRs) for measuring monthly caffeine and caffeinated beverage intakes; and 2) validity of the 24H

27 ding to their reported current and long-time caffeinated beverage use into one of three groups: low [

28 nalysis revealed that oral administration of caffeinated beverages (green tea, black tea, decaffeinat

29 en the common consumption of coffee or other caffeinated beverages and a reduced risk of developing P

30 nted on the association between caffeine and caffeinated beverages and reproductive hormones and whet

31 occupy up to 50% of the cerebral A(1)AR when caffeinated beverages are repeatedly consumed during a d

32 Caffeinated beverages are widely consumed among women of

33 tudy data to test whether the consumption of caffeinated beverages exhibits this protective effect.

34 Habitual intake of caffeinated beverages provided protection against the ri

35 Consumption of caffeinated beverages such as coffee and tea has been as

36 ption of carbonated beverages is confined to caffeinated beverages.

37 uestions on the use of tobacco, alcohol, and caffeinated beverages.

38 gas chromatography of each subject's brewed, caffeinated beverages.

39 Multiple human epidemiologic studies link caffeinated (but not decaffeinated) beverage intake with

40 ncreasing categories of consistent intake of caffeinated coffee (0, 1, 2-3, and > or =4 cups/day) wer

41 mol/l among women consuming >/=4 cups/day of caffeinated coffee and 23.0 nmol/l among nondrinkers (P

42 Caffeinated coffee and daily caffeine intake were not as

43 duced shortly after ingestion of caffeine or caffeinated coffee and suggesting that coffee consumptio

44 iabetes for women consuming >/=4 cups/day of caffeinated coffee compared with nondrinkers was 0.47 (9

45 rd lower risk of stroke after adjustment for caffeinated coffee consumption (RR for >or=2 cups a day

46 s to assess the association between filtered caffeinated coffee consumption and all-cause and CVD mor

47 t inverse association was also found between caffeinated coffee consumption and BCC risk.

48 there was no relationship between cumulative caffeinated coffee consumption and RA risk (RR 1.1, 95%

49 In women with type 2 diabetes, higher caffeinated coffee consumption was associated with lower

50 to abstainers, those who drank >/= 3 cups of caffeinated coffee daily were at increased risk of EG/EG

51 ver, for consumption of five or more cups of caffeinated coffee daily, the RR was 1.61 (95% CI, 1.00-

52 Patients consuming 4 cups/d or more of caffeinated coffee experienced significantly reduced can

53 lele of SHBG gene consuming >/=2 cups/day of caffeinated coffee had lower risk of type 2 diabetes in

54 Caffeine and caffeinated coffee have been shown to acutely increase b

55 n were measured after 14 d of consumption of caffeinated coffee high in chlorogenic acid (C-HCA), dec

56 p of participants with a low or no intake of caffeinated coffee in the HPFS cohort.

57 High caffeinated coffee intake also was not associated with r

58 Women reported less caffeinated coffee intake in their 24HDRs compared with

59 two other cognitive function tests; current caffeinated coffee intake was associated with better per

60 In this large prospective study, caffeinated coffee intake was inversely associated with

61 prior day's diary record for measuring daily caffeinated coffee intake.

62 the markers were found across categories of caffeinated coffee intake.

63 Compared with individuals who consumed caffeinated coffee less than 1 cup per month, women who

64 These data suggest that consumption of caffeinated coffee may play a role in the prevention of

65 Neither caffeinated coffee nor caffeine intake was associated wi

66 ese analyses indicate a beneficial impact of caffeinated coffee on liver morphology and/or function,

67 American women who drink moderate amounts of caffeinated coffee or alcohol have a reduced risk of typ

68 feinated coffee per day], moderate (3-4 cups caffeinated coffee per day), or high (> or = 5 cups caff

69 ated coffee per day), or high (> or = 5 cups caffeinated coffee per day).

70 ups: low [0-2 cups (180 mL, or 6 oz per cup) caffeinated coffee per day], moderate (3-4 cups caffeina

71 Caffeinated coffee showed significant inverse associatio

72 odds ratio for drinking > or = 4 cups/day of caffeinated coffee versus drinking < or = 1 cup/week was

73 Intake of >4 cups/day of caffeinated coffee was associated with a 49% lower risk

74 Consumption of filtered caffeinated coffee was not associated with CVD or all-ca

75 Caffeinated coffee was positively associated with SHBG b

76 r each 240-ml (8-oz) serving consumed daily: caffeinated coffee, 10% (95% confidence interval 4-15%);

77 ving consumed daily: 10% (CI, 5% to 15%) for caffeinated coffee, 9% (CI, 2% to 15%) for decaffeinated

78 Higher consumption of total coffee, caffeinated coffee, and decaffeinated coffee was associa

79 and total caffeine intake (mg/d) or cups of caffeinated coffee, decaffeinated coffee, and caffeinate

80 In summary, these findings suggest that caffeinated coffee, decaffeinated coffee, and caffeine a

81 Intakes of caffeinated coffee, decaffeinated coffee, and caffeine w

82 ined the associations of baseline intakes of caffeinated coffee, decaffeinated coffee, and caffeine w

83 The mean intakes of caffeinated coffee, decaffeinated coffee, and caffeine w

84 The authors examined associations of caffeinated coffee, decaffeinated coffee, and tea intake

85 The authors investigated the association of caffeinated coffee, decaffeinated coffee, and tea with m

86 e sought to assess longitudinal relations of caffeinated coffee, decaffeinated coffee, and total caff

87 women who consistently reported consuming no caffeinated coffee, the multivariate relative risks (adj

88 those overall for drinkers of predominantly caffeinated coffee.

89 for intakes of 0-1, 1, 2-3, and >/=4 cups of caffeinated coffee/d relative to no coffee intake were 0

90 , 19%) lower risk of stroke and 1 serving of caffeinated coffee/d with a 9% (95% CI: 0%, 17%) lower r

91 healthy women consumed > or =1 cup (237 mL) caffeinated coffee/mo and 75% consumed > or =1 cup decaf

92 % CI, 1.00-2.59; P for trend = 0.02); tea or caffeinated cola intake were not associated with risk.

93 to prospectively examine the association of caffeinated compared with caffeine-free beverages, inclu

94 We found that 24 hr of exposure to a caffeinated diet desensitized all of the caffeine-respon

95 recently increased soda intake, particularly caffeinated diet soda, had higher symptom scores, urgenc

96 Answer: No--at least, not in the brain of a caffeinated dopamine-deficient (DD) mutant mouse.

97 offee use was more prevalent than the use of caffeinated drinks and caffeine tablets.

98 in which the consumption of coffee and other caffeinated drinks was assessed starting in 1986 as part

99 were surveyed regarding their use of coffee, caffeinated drinks, and caffeine tablets for CE and pote

100 offee use; 24.2%, 15.4%, 9.9%, and 6.1%, for caffeinated drinks; and 12.6%, 5.9%, 4.7%, and 3.8%, res

101 epiness, many teens regularly consume highly caffeinated energy drinks and other stimulants, creating

102 A lower risk of T2D was associated with caffeinated (HR: 0.77; 95% CI: 0.63, 0.94; P-trend 0.009

103 Caffeinated (HR: 0.94; 95% CI: 0.84, 1.05) or decaffeina

104 d data, the wider ecological significance of caffeinated nectar remains difficult to interpret.

105 These results indicate that neither caffeinated nor decaffeinated filtered coffee has a detr

106 stantiate recommendations for restriction of caffeinated or acidic beverages as self-management for l

107 ctions in risk were seen for substitution of caffeinated or decaffeinated coffee for low-calorie soda

108 offee with additives.Drinking coffee, either caffeinated or decaffeinated, may lower the risk of CVD

109 icant inverse associations were observed for caffeinated (P value for trend < 0.001) and decaffeinate

110 find associations with consumption of other caffeinated products (caffeinated soda, caffeinated tea,

111 scontinued or substantially curtailed use of caffeinated products because of associated anxiety and d

112 ol concentrations among white women, whereas caffeinated soda and green tea intakes were associated w

113 o more than 2 cups of coffee or four cans of caffeinated soda daily), caffeine intake was positively

114 Caffeinated soda intake and green tea intake >/=1 cup/d

115 h consumption of other caffeinated products (caffeinated soda, caffeinated tea, decaffeinated coffee

116 examined the hypothesis that consumption of caffeinated soft drinks in childhood is associated with

117 percentage body fat, greater consumption of caffeinated soft drinks was associated with a higher ris

118 r drinks containing caffeine such as tea and caffeinated soft drinks were not associated with stroke.

119 m of brewed coffee, instant coffee, tea, and caffeinated soft drinks, as well as caffeine intoxicatio

120 k of T2D in the NHS (RR per serving: 13% for caffeinated SSBs, 11% for caffeine-free SSBs; P < 0.05)

121 05) and in the HPFS (RR per serving: 16% for caffeinated SSBs, 23% for caffeine-free SSBs; P < 0.01).

122 Surgeons often use caffeinated substances to cope with fatigue and long wor

123 rviewers assessed self-reported usual weekly caffeinated tea consumption during the year before infar

124 Only caffeinated tea was associated with a lower T2D risk amo

125 ther caffeinated products (caffeinated soda, caffeinated tea, decaffeinated coffee or chocolate) and

126 affeinated coffee, decaffeinated coffee, and caffeinated tea.